| Inducible nitric oxide synthase: Good or bad? M Lind, A Hayes, M Caprnda, D Petrovic, L Rodrigo, P Kruzliak, A Zulli Biomedicine & Pharmacotherapy 93, 370-375, 2017 | 251 | 2017 |
| Pathophysiology of myocardial infarction and acute management strategies M Tibaut, D Mekis, D Petrovic Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2016 | 149 | 2016 |
| Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases A Berezin, A Zulli, S Kerrigan, D Petrovic, P Kruzliak Clinical biochemistry 48 (9), 562-568, 2015 | 147 | 2015 |
| Relationship between method of anastomosis and anastomotic failure after right hemicolectomy and ileo‐caecal resection: an international snapshot audit 2015 European Society of Coloproctology Collaborating Group, ... Colorectal Disease 19 (8), e296-e311, 2017 | 136 | 2017 |
| Melatonin and breast cancer: Evidences from preclinical and human studies P Kubatka, P Zubor, D Busselberg, TK Kwon, M Adamek, D Petrovic, ... Critical reviews in oncology/hematology 122, 133-143, 2018 | 132 | 2018 |
| Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy MG Petrovič, P Korošec, M Košnik, J Osredkar, M Hawlina, B Peterlin, ... Molecular Vision 14, 1382, 2008 | 124 | 2008 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 115 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 101 | 2020 |
| Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial … M Proietti, GYH Lip, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 23 (2), 174-183, 2021 | 92 | 2021 |
| Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes D Petrovič, R Verhovec, M Globočnik Petrovič, J Osredkar, B Peterlin Cardiology 107 (4), 291-295, 2007 | 86 | 2007 |
| A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians T Kunej, MG Petrovic, P Dovc, B Peterlin, D Petrovic FOLIA BIOLOGICA-PRAHA- 50 (5), 157-158, 2004 | 83 | 2004 |
| Candidate genes for proliferative diabetic retinopathy D Petrovič BioMed research international 2013 (1), 540416, 2013 | 79 | 2013 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 77 | 2022 |
| Markers of atherosclerosis: part 1–serological markers M Tibaut, M Caprnda, P Kubatka, A Sinkovič, V Valentova, S Filipova, ... Heart, Lung and Circulation 28 (5), 667-677, 2019 | 75 | 2019 |
| Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients MG Petrovič, I Cilenšek, D Petrovič Disease Markers 24 (1), 59-64, 2008 | 74 | 2008 |
| Ventricular and vascular remodelling–effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients J Petrovic, D Petrovic, N Vukovic, B Zivanovic, J Dragicevic, Z Vasiljevic, ... Journal of International Medical Research 33 (1_suppl), 39A-49A, 2005 | 74 | 2005 |
| GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy I Cilenšek, S Mankoč, MG Petrovič, D Petrovič Disease markers 32 (2), 93-99, 2012 | 72 | 2012 |
| Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 21 (7), 1013-1022, 2019 | 66 | 2019 |
| Mesenchymal stem cells in the treatment of type 1 diabetes mellitus J Katuchova, D Harvanova, T Spakova, R Kalanin, D Farkas, P Durny, ... Endocrine pathology 26, 95-103, 2015 | 66 | 2015 |
| M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in Caucasians N Glavnik, D Petrovic FOLIA BIOLOGICA-PRAHA- 53 (2), 69, 2007 | 61 | 2007 |
